Skip to main content
SpringerLink
Log in

Human platelet 5-hydroxytryptamine receptors: Binding of [3H]-lysergic acid diethylamide (LSD). Effects of chronic neuroleptic and antidepressant drug administration

  • Multi-author Review
  • The Platelet in Pathophysiological Research
  • Published:
Experientia Aims and scope Submit manuscript

Summary

Chronic treatment with phenothiazines and thioxanthenes has been found to enhance 5-HT-induced aggregation of human platelets. A method has been developed to study 5-HT2 receptor binding sites on platelets utilising [3H]-LSD and more recently125I/LSD. Results are presented which suggest that the LSD binding site is indeed the 5-HT2 binding site and that the LSD binding characterises the specific receptor responsible for 5-HT-induced shape change and aggregation.

In a group of patients receiving phenothiazines or thioxanthenes, theB max of LSD binding was increased. The mean binding affinity was decreased possibly due to a persistence of neuroleptic in the platelet membrane preparation. Analysis showed that this was not the reason why the mean binding capacity was increased.

The results show that chronic phenothiazine and thioxanthene δ treatment ‘up-regulates’ platelet 5-HT2 binding sites and that this may be accompanied by increased sensitivity to platelet aggregation by 5-HT.

In normal subjects desipramine treatment increased theB max of platelet LSD binding and this was accompanied by an increased prolactin response to tryptophan which is thought to be mediated by central 5-HT function.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Anderson, I. M., and Cowen, P. J., Clomipramine enhances prolactin and growth hormone responses tol-tryptophan. Psychopharmacology89 (1986) 131–133.

    Article  CAS  PubMed  Google Scholar 

  2. Bennet, J. P., and Snyder, S. H., Stereospecific binding ofd-lysergic acid diethylamide (LSD) to brain membranes: relationship to serotonin receptors. Brain Res.94 (1975) 523.

    Article  Google Scholar 

  3. Baldacci, M., Bergel, T. D., Born, G. V. R., and Hickman, M., Increases in aggregation by uptake of 5-hydroxytryptamine with platelets from rabbits treated with chlorpromazine. Br. J. Pharmac. Chemother.69 (1980) 113–118.

    Article  CAS  Google Scholar 

  4. Boullin, D. J., Grahame-Smith, D. G., Grimes, R. P. J., and Woods, H. F., Inhibition of hydroxytryptamine induced human blood platelet aggregation by chlorpromazine and its metabolites. Br. J. Pharmac. Chemother.53 (1975) 121–125.

    Article  CAS  Google Scholar 

  5. Boullin, D. J., Woods, H. F., Grimes, R. P. J., Grahame-Smith, D. G., Wiles, D., Gelder, M. G., and Kolakowska, T., Increased platelet aggregation responses to 5-hydroxytryptamine in patients taking chlorpromazine. Br. J. clin. Pharmac.2 (1975) 29–35.

    Article  CAS  Google Scholar 

  6. Boullin, D. J., Orr, M. W., and Peters, J. R., The platelet as a model for investigating clinical efficacy of centrally acting drugs: relations between platelet aggregation and clinical condition in schizophrenics treated with chlorpromazine, in: Platelets: a Multi-disciplinary Approach. Eds S. E. de Gaetano and S. Gorathine. Raven Press, New York 1978.

    Google Scholar 

  7. Boullin, D. J., Knox, J. M., Peters, J., and Orr, M., Platelet aggregation and chlorpromazine therapy. Br. J. clin. Pharmac.6 (1978) 538–540.

    Article  CAS  Google Scholar 

  8. Cowen, P. J., and Anderson, I. M., in: Recent advances in the biology of depression. Eds. J. F. W. Deakin and H. Freeman. Royal College of Psychiatrists, special publication, 1986.

  9. Cowen, P. J., Geaney, D. P., Schacter, M., Green, A. R., and Elliott, M. J., Desipramine treatment in normal subjects effects on neuroendocrine response to tryptophan and on platelet serotonin (5-HT)-related receptors. Archs gen. Psychiat.43 (1986) 61–67.

    Article  CAS  Google Scholar 

  10. Cross, A. J., Interactions of [3H]-LSD with serotonin receptors in human brain. Eur. J. Pharmac.82 (1982) 77.

    Article  CAS  Google Scholar 

  11. Dawbarn, D., Long, S. K., and Pycock, C. J., Increased central 5-hydroxytryptamine receptor mechanisms in rats after chronic neuroleptic treatment. Br. J. Pharmac. Chemother.73 (1981) 149–156.

    Article  CAS  Google Scholar 

  12. Geaney, D. P., Schacter, M., Elliott, J. M., and Grahame-Smith, D. G., Characterization of [3H]-Lysergic acid diethylamide binding to a 5-hydroxytryptamine receptor on human platelet membranes. Eur. J. Pharmac.97 (1984) 87–93.

    Article  CAS  Google Scholar 

  13. Glue, P. W., Cowen, P. J., Nutt, D. J., Kolakowska, T., and Grahame-Smith, D. G., The effect of Lithium on 5-HT mediated neuroendocrine responses and platelet 5-HT receptors. Psychopharmacology90 (1986) 398–402.

    Article  CAS  PubMed  Google Scholar 

  14. Hefez, A., Oppenheim, B., and Youdim, M. B. H., Human platelet aggregation response to serotonin as an index of efficacy of chlorpromazine, in: Enzymes and Neurotransmitters in Mental Disease, pp. 77–93. Eds E. Usdin, T. L. Sourkes and M. B. H. Youdim. John Wiley, New York 1980.

    Google Scholar 

  15. Knox, J. M., Orr, M. W., Allen, R., Gelder, M. G., and Grahame-Smith, D. G., The reliability of 5-hydroxytryptamine reduced platelet aggregation responses in schizophrenic patients with neuroleptic drugs. Br. J. clin. Pharmac.11 (1981) 261–263.

    Article  CAS  Google Scholar 

  16. Laubscher, A., and Pletscher, A., Shape change and uptake of 5-hydroxytryptamine in human blood platelets: actions of neuropsychotropic drugs. Life Sci.24 (1979) 1833.

    Article  CAS  PubMed  Google Scholar 

  17. Laubscher, A., Pletscher, A., and Noll, H., Interaction ofd-LSD with blood platelets of rabbits: shape, change and specific binding. J. Pharmac. exp. Ther.216 (1981) 385.

    CAS  Google Scholar 

  18. Leysen, J. E., Commeren, W., and de Clerck, F., Demonstration of S2-receptor binding sites in cat platelets using [3H]-ketanserin. Eur. J. Pharmac.88 (1983) 125–130.

    Article  CAS  Google Scholar 

  19. Mills, D. C. B., and Roberts, G. C. K., Membrane active drugs and the aggregation of human blood platelets. Nature213 (1967) 35–38.

    Article  CAS  Google Scholar 

  20. Orr, M. W., and Boullin, D. J., The relationship between changes in 5-HT induced platelet aggregation and the clinical state in patients treated with fluphenazine. Br. J. clin. Pharmac.3 (1976) 925–928.

    Article  CAS  Google Scholar 

  21. Orr, M. W., Knox, J. M., Allen, R., Gelder, M. G., and Grahame-Smith, D. G., The effects of neuroleptic drugs on 5-hydroxytryptamine induced platelet aggregation in schizophrenic patients. Br. J. clin. Pharmac.11 (1981) 255–259.

    Article  CAS  Google Scholar 

  22. Peroutka, S. J., and Snyder, S. H., Multiple serotonin receptors differential binding of [3H]-5-hydroxytryptamine, [3H]-lysergic acid diethylamide and [3H]-spiroperidol. Molec. Pharmac.16 (1979) 687–698.

    CAS  Google Scholar 

  23. Peroutka, S. J., and Snyder, S. H., Long-term antidepressant treatment decreases spiroperidol-labelled serotonin receptor treatment. Science210 (1980) 88–90.

    Article  CAS  PubMed  Google Scholar 

  24. Peters, J. R., and Grahame-Smith, D. G., Human platelet 5-HT receptors: characterisation and functional association. Eur. J. Pharmac.68 (1980) 243.

    Article  Google Scholar 

  25. Schacter, M., Geaney, D. P., Grahame-Smith, D. G., Cowen, P., and Elliott, J. M., Increased platelet membrane [3H]-LSD binding in patients on chronic neuroleptic treatment. Br. J. clin. Pharmac.19 (1985) 453–457.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. MRC Unit and University Department of Clinical Pharmacology, Radcliffe Infirmary, OX2 6HE, Oxford, England

    D. G. Grahame-Smith, D. P. Geaney, M. Schachter & J. M. Elliott

Authors
  1. D. G. Grahame-Smith
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. P. Geaney
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Schachter
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. M. Elliott
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Grahame-Smith, D.G., Geaney, D.P., Schachter, M. et al. Human platelet 5-hydroxytryptamine receptors: Binding of [3H]-lysergic acid diethylamide (LSD). Effects of chronic neuroleptic and antidepressant drug administration. Experientia 44, 142–145 (1988). https://doi.org/10.1007/BF01952198

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01952198

Key words

Search

Navigation